| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |